Polymerase chain reaction
hideIn molecular biology, the polymerase chain reaction (PCR) is a technique to amplify a single or few copies of a piece of DNA across several orders of magnitude, generating millions or more copies of a particular DNA sequence. The method relies on thermal cycling, consisting of cycles of repeated heating and cooling of the reaction for DNA melting and enzymatic replication of the DNA. Primers (short DNA fragments) containing sequences complementary to the target region along with a DNA polymerase (after which the method is named) are key components to enable selective and repeated amplification. As PCR progresses, the DNA generated is itself used as a template for replication, setting in motion a chain reaction in which the DNA template is exponentially amplified. PCR can be extensively modified to perform a wide array of genetic manipulations.
Almost all PCR applications employ a heat-stable DNA polymerase, such as Taq polymerase, an enzyme originally isolated from the bacterium Thermus aquaticus. This DNA polymerase enzymatically assembles a new DNA strand from DNA building blocks, the nucleotides, by using single-stranded DNA as a template and DNA oligonucleotides (also called DNA primers), which are required for initiation of DNA synthesis. The vast majority of PCR methods use thermal cycling, i.e., alternately heating and cooling the PCR sample to a defined series of temperature steps. These thermal cycling steps are necessary to physically separate the strands (at high temperatures) in a DNA double helix (DNA melting) used as the template during DNA synthesis (at lower temperatures) by the DNA polymerase to selectively amplify the target DNA. The selectivity of PCR results from the use of primers that are complementary to the DNA region targeted for amplification under specific thermal cycling conditions.
Developed in 1984 by Kary Mullis, PCR is now a common and often indispensable technique used in medical and biological research labs for a variety of applications. These include DNA cloning for sequencing, DNA-based phylogeny, or functional analysis of genes; the diagnosis of hereditary diseases; the identification of genetic fingerprints (used in forensic sciences and paternity testing); and the detection and diagnosis of infectious diseases. In 1993 Mullis was awarded the Nobel Prize in Chemistry for his work on PCR.
For more information about Polymerase chain reaction, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with polymerase chain reaction
Test Detects Insect Carriers of Citrus Greening Disease
Oct 26, 2009 |
not rated yet |
0
(PhysOrg.com) -- With their pleasing flavor, cheerful color, and health-imparting dose of vitamin C, it's not surprising that oranges are one of America's Top 10 favorite fruits. But some of the nation's citrus ...
New microRNA Data Could Classify Bladder Cancer by Type
Oct 22, 2009 |
not rated yet |
0
(PhysOrg.com) -- Data published in Cancer Research, a journal of the American Association for Cancer Research, offers new insights into the biology of urothelial carcinoma of the bladder. Specifically, microRNA profiles differ ...
Catching a killer one spore at a time
Oct 19, 2009 |
not rated yet |
0
A workshop at the Smithsonian Tropical Research Institute in Panama has dramatically improved the ability of conservationists and regulatory agencies to monitor the spread of chytridiomycosis—one of the deadliest ...
Goodbye 'R' rule? Oyster pathogen test may help make shellfish safer
Oct 14, 2009 |
not rated yet |
0
(PhysOrg.com) -- The oyster lover’s axiom of edibility -- that this shellfish is safest to eat in any month with an 'r' in it -- may soon become somewhat of a culinary anachronism, thanks to a new food-safety test developed ...
Polyclonality of BRAF mutations in acquired melanocytic nevi
Sep 14, 2009 |
not rated yet |
0
The polyclonality of BRAF mutations in melanocytic nevi suggests that mutation of BRAF may not be an initial event in melanocyte transformation, according to a new brief communication published online September 14 in the ...
Test developed at UQ diagnosed Australia's first swine flu victim
Sep 03, 2009 |
not rated yet |
0
When the first cases of H1N1 Influenza (swine flu) were reported in Mexico in April, UQ researchers got to work developing a test to diagnose the virus.
A better test to detect DNA for diagnosing diease, investigating crimes
Aug 26, 2009 |
5 / 5 (3) |
1
Researchers in Singapore are reporting development of a new electronic sensor that shows promise as a faster, less expensive, and more practical alternative than tests now used to detect DNA. Such tests are ...
Monitoring Cancer Cell Changes With Quantum Dots
Nanotechnology / Bio & Medicine
Jul 23, 2009 |
5 / 5 (1) |
0
One of the earliest events that changes a normal cell into a malignant one is known as deoxyribonucleic acid (DNA) hypermethylation, a biochemical alteration that inactivates critical tumor-suppressor genes. A team of investigators ...
Faster, more cost-effective DNA test for crime scenes, disease diagnosis
Chemistry / Analytical Chemistry
Jul 08, 2009 |
4 / 5 (1) |
0
Scientists in Japan are reporting development of a faster, less expensive version of the fabled polymerase chain reaction (PCR) a DNA test widely used in criminal investigations, disease diagnosis, biological ...
Ultrasensitive detector promises improved treatment of viral respiratory infections
Chemistry / Analytical Chemistry
Jun 29, 2009 |
not rated yet |
0
(PhysOrg.com) -- A Vanderbilt chemist and a biomedical engineer have teamed up to develop a respiratory virus detector that is sensitive enough to detect an infection at an early stage, takes only a few minutes ...
Rapid approach to identify influenza A virus mutations and drug resistance developed
May 28, 2009 |
not rated yet |
0
Genome Institute of Singapore scientists, led by Christopher Wong, Ph.D., have developed a novel approach to uncover the complete sequence of any influenza A virus, including H1NI, with just a quick nasal swab or nasal pharyngeal ...
FluChip technology licensed to combat deadly flu virus
Apr 28, 2009 |
1 / 5 (1) |
0
InDevR, a small biotech company in Boulder, CO, announced today that they have licensed the FluChip technology from the University of Colorado. The FluChip was invented by a joint team of scientists at the University of ...
